_id

690f3d2dccc777a4e85d1a8c

Ticker

CDTX

Name

Cidara Therapeutics Inc

Exchange

NASDAQ

Address

6310 Nancy Ridge Drive, San Diego, CA, United States, 92121

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.cidara.com

Description

Cidara Therapeutics, Inc. operates as a biotechnology company that focuses on developing targeted therapies for patients facing cancers and other serious diseases. The company's product includes rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also develops its Cloudbreak platform that enables development of novel drug-Fc conjugates, that includes CD388, a potent antiviral designed to deliver universal prevention and treatment of seasonal and pandemic influenza, which is in Phase 1 and Phase 2a clinical trials. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in July 2014. Cidara Therapeutics, Inc. was incorporated in 2012 and is based in San Diego, California.

Last Close

220.19

Volume

490934

Current Price

220.65

Change

0.20891048639811433

Last Updated

2025-11-29T11:17:58.403Z

Image

data:image/webp;base64,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

Ipo Date

2015-04-15T00:00:00.000Z

Market Cap

6914414080

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.7604310344827586

Sentiment Sources

58

Rating

4.4

Target Price

209.375

Strong Buy

2

Buy

3

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

45000000

Gross Profit

-45000000

Operating Expenses

43628000

Operating Income

-88628000

Interest Expense

-

Pretax Income

-83233000

Net Income

-83233000

Eps

-5.353498587513298

Dividends Per Share

-

Shares Outstanding

31446306

Income Tax Expense

-

EBITDA

-83205000

Operating Margin

-

Total Other Income Expense Net

5395000

Cash

293651000

Short Term Investments

126370000

Receivables

1861000

Inventories

-

Total Current Assets

442821000

Property Plant Equipment

2088000

Total Assets

518650000

Payables

4351000

Short Term Debt

1560000

Long Term Debt

-

Total Liabilities

96263000

Equity

422387000

Depreciation

28000

Change In Working Capital

39259000

Cash From Operations

-40615000

Capital Expenditures

0

Cash From Investing

-176470000

Cash From Financing

160000

Net Change In Cash

-216925000

PE

-

PB

8.121780433465045

ROE

-19.705388660162363

ROA

-16.048009254796106

FCF

-40615000

Fcf Percent

-

Piotroski FScore

1

Health Score

35

Deep Value Investing Score

3

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

3.8

Garp Investing Score

2

Growth Investing Score

0.5

Momentum Investing Score

2

Net Net Investing Score

2.5

Quality Investing Score

2.5

Value Investing Score

3

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

45000000

Quarters > 0 > income Statement > gross Profit

-45000000

Quarters > 0 > income Statement > operating Expenses

43628000

Quarters > 0 > income Statement > operating Income

-88628000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-83233000

Quarters > 0 > income Statement > net Income

-83233000

Quarters > 0 > income Statement > eps

-5.353498587513298

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

15547403

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-83205000

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

5395000

Quarters > 0 > balance Sheet > cash

293651000

Quarters > 0 > balance Sheet > short Term Investments

126370000

Quarters > 0 > balance Sheet > receivables

1861000

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

442821000

Quarters > 0 > balance Sheet > property Plant Equipment

2088000

Quarters > 0 > balance Sheet > total Assets

518650000

Quarters > 0 > balance Sheet > payables

4351000

Quarters > 0 > balance Sheet > short Term Debt

1560000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

96263000

Quarters > 0 > balance Sheet > equity

422387000

Quarters > 0 > cash Flow > net Income

-83233000

Quarters > 0 > cash Flow > depreciation

28000

Quarters > 0 > cash Flow > change In Working Capital

39259000

Quarters > 0 > cash Flow > cash From Operations

-40615000

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

-176470000

Quarters > 0 > cash Flow > cash From Financing

160000

Quarters > 0 > cash Flow > net Change In Cash

-216925000

Quarters > 0 > ratios > PE

-5.353498587513298

Quarters > 0 > ratios > PB

8.121780433465045

Quarters > 0 > ratios > ROE

-19.705388660162363

Quarters > 0 > ratios > ROA

-16.048009254796106

Quarters > 0 > ratios > FCF

-40615000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

35

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

27000

Quarters > 1 > income Statement > gross Profit

-27000

Quarters > 1 > income Statement > operating Expenses

27384000

Quarters > 1 > income Statement > operating Income

-27384000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-25718000

Quarters > 1 > income Statement > net Income

-25718000

Quarters > 1 > income Statement > eps

-1.6541669370762435

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

15547403

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-27357000

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

1666000

Quarters > 1 > balance Sheet > cash

510575000

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

1859000

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

531791000

Quarters > 1 > balance Sheet > property Plant Equipment

2441000

Quarters > 1 > balance Sheet > total Assets

534327000

Quarters > 1 > balance Sheet > payables

2206000

Quarters > 1 > balance Sheet > short Term Debt

1497000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

33154000

Quarters > 1 > balance Sheet > equity

501173000

Quarters > 1 > cash Flow > net Income

-25718000

Quarters > 1 > cash Flow > depreciation

27000

Quarters > 1 > cash Flow > change In Working Capital

-14604000

Quarters > 1 > cash Flow > cash From Operations

-40961000

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

-

Quarters > 1 > cash Flow > cash From Financing

383385000

Quarters > 1 > cash Flow > net Change In Cash

342424000

Quarters > 1 > ratios > PE

-1.6541669370762435

Quarters > 1 > ratios > PB

6.845010549151691

Quarters > 1 > ratios > ROE

-5.131561357056346

Quarters > 1 > ratios > ROA

-4.813157485958973

Quarters > 1 > ratios > FCF

-40961000

Quarters > 1 > ratios > Piotroski FScore

0

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

34

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

49000

Quarters > 2 > income Statement > gross Profit

-49000

Quarters > 2 > income Statement > operating Expenses

25269000

Quarters > 2 > income Statement > operating Income

-25269000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-23480000

Quarters > 2 > income Statement > net Income

-23480000

Quarters > 2 > income Statement > eps

-1.6561169150830284

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

14177743

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-25220000

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

1789000

Quarters > 2 > balance Sheet > cash

168150000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

1694000

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

188848000

Quarters > 2 > balance Sheet > property Plant Equipment

2783000

Quarters > 2 > balance Sheet > total Assets

191727000

Quarters > 2 > balance Sheet > payables

4897000

Quarters > 2 > balance Sheet > short Term Debt

1437000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

50045000

Quarters > 2 > balance Sheet > equity

141682000

Quarters > 2 > cash Flow > net Income

-23480000

Quarters > 2 > cash Flow > depreciation

49000

Quarters > 2 > cash Flow > change In Working Capital

4828000

Quarters > 2 > cash Flow > cash From Operations

-21950000

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

185000

Quarters > 2 > cash Flow > cash From Financing

77000

Quarters > 2 > cash Flow > net Change In Cash

-21688000

Quarters > 2 > ratios > PE

-1.6561169150830284

Quarters > 2 > ratios > PB

22.07986189459494

Quarters > 2 > ratios > ROE

-16.57232393670332

Quarters > 2 > ratios > ROA

-12.246579772280377

Quarters > 2 > ratios > FCF

-21950000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

35

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

0

Quarters > 3 > income Statement > cost Of Revenue

83263000

Quarters > 3 > income Statement > gross Profit

-90753000

Quarters > 3 > income Statement > operating Expenses

54182000

Quarters > 3 > income Statement > operating Income

-54182000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-52369000

Quarters > 3 > income Statement > net Income

-52307000

Quarters > 3 > income Statement > eps

-5.377071411727191

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

9727786

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-54123000

Quarters > 3 > income Statement > operating Margin

-

Quarters > 3 > income Statement > total Other Income Expense Net

1813000

Quarters > 3 > balance Sheet > cash

189825000

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

1694000

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

210737000

Quarters > 3 > balance Sheet > property Plant Equipment

3963000

Quarters > 3 > balance Sheet > total Assets

214796000

Quarters > 3 > balance Sheet > payables

3608000

Quarters > 3 > balance Sheet > short Term Debt

1642000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

51488000

Quarters > 3 > balance Sheet > equity

163308000

Quarters > 3 > cash Flow > net Income

-52307000

Quarters > 3 > cash Flow > depreciation

59000

Quarters > 3 > cash Flow > change In Working Capital

20869000

Quarters > 3 > cash Flow > cash From Operations

-29414000

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

-

Quarters > 3 > cash Flow > cash From Financing

98205000

Quarters > 3 > cash Flow > net Change In Cash

68791000

Quarters > 3 > ratios > PE

-5.377071411727191

Quarters > 3 > ratios > PB

13.143483362113308

Quarters > 3 > ratios > ROE

-32.029661743454085

Quarters > 3 > ratios > ROA

-24.351943239166467

Quarters > 3 > ratios > FCF

-29414000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-

Quarters > 3 > health Score

35

Valuation > metrics > PE

-5.353498587513298

Valuation > metrics > PB

8.121780433465045

Valuation > final Score

20

Valuation > verdict

170.7% Overvalued

Profitability > metrics > ROE

-19.705388660162363

Profitability > metrics > ROA

-18.796082389949888

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.22790237388934792

Risk > metrics > Interest Coverage

-3165.285714285714

Risk > final Score

-12601

Risk > verdict

High

Liquidity > metrics > Current Ratio

74.9147352393842

Liquidity > metrics > Quick Ratio

74.9147352393842

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

20

Prev Valuations > 1

20

Prev Valuations > 2

20

Prev Profitabilities > 0

15

Prev Profitabilities > 1

15

Prev Profitabilities > 2

15

Prev Risks > 0

-7

Prev Risks > 1

2

Prev Risks > 2

-64

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:19:32.766Z